Furthermore, DHA inhibits activation of the AIM2 inflammasome pathway and NF-κB/HIF-1α/VEGF pathway by promoting autophagy in A431 cells, thus exerting a therapeutic effect against cSCC. This evidence concerns the gene HIF1A and skin squamous cell carcinoma.